« Previous
Next »
The Journal of Heart and Lung Transplantation
Volume 28, Issue 7
, Pages 704-709
, July 2009
The Change in B-Type Natriuretic Peptide Levels Over Time Predicts Significant Rejection in Cardiac Transplant Recipients
References
- . Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19:43–47
- . Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep. 2000;2:198–205
- . Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825–832
- Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9–13
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
- Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant. 2004;23:1189–1197
- Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509–516
- B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
- Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 2001;86:21–26
- . Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997;47:287–296
- . Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart. 2004;90:297–303
- NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003;89:150–154
- N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail. 2004;6:335–341
- NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail. 2004;6:343–350
- B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant. 2005;24:1444
- . Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant. 2005;24:52–57
- Neuroendocrine profiling of humans receiving cardiac allografts. J Heart Lung Transplant. 2005;24:1046–1054
- . Is brain natriuretic peptide clinically useful after cardiac transplantation?. J Heart Lung Transplant. 2006;25:1396–1401
- Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant. 2005;24:416–420
- . B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant. 2004;23:558–563
- Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant. 2004;23:850–856
- Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–1720
- . Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049–1060
- . Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens (Rapamycin Cardiac Rejection Treatment Trial Pathologists). J Heart Lung Transplant. 1996;15:728–735
- . The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant. 1998;17:754–760
- . Reproducibility of the acute rejection diagnosis in human cardiac allografts (The Stanford Classification and the International Grading System). J Heart Lung Transplant. 1993;12:239–243
- . Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation. 1999;100:287–291
- Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation. J Heart Lung Transplant. 2008;27:735–740
- Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006;6:150–160
PII: S1053-2498(09)00241-1
doi: 10.1016/j.healun.2009.04.019
© 2009 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Heart and Lung Transplantation
Volume 28, Issue 7
, Pages 704-709
, July 2009
